21 Biotech Startups in Lausanne to Watch in 2024
How do we build this list?
Last update to the database: May 26, 2024. See changelog.
Join 23,000+ founders, operators and investors.
Seedtable Score Learn how we calculate it here
We use raw data and human intuition to understand if a company is likely to outsource services like Hiring, Design, Development, etc.
company | score | funding | investors | employees | industries | biz model | city | contact |
---|---|---|---|---|---|---|---|---|
Small molecule mitophagy inducers developer. |
$20M · Series A | ND Capital | 1 to 10 | Health Tech, Biotech | Lausanne, Switzerland | •••••••••••@vandria.com | ||
RNA sequencing and transcriptomics analysis platform. |
$3M · Seed | Novalis Biotechnology Incubation, TechU Ventures, Foundation for Technological Innovation (FIT) | 1 to 10 | Health Tech, Biotech | B2B | Lausanne, Switzerland | •••••••••••@alitheagenomics.com | |
Platform providing digital assessments and therapies for patient treatment and rehabilitation. |
$125M | Hambro Perks Ltd. | 101 to 250 | Health Tech, AR / VR, Biotech, Deep Tech, Business Intelligence | B2B | Lausanne, Switzerland | •••••••••••@mindmaze.com | |
Manufacturer of drugs to combat the effects of ageing. |
$10M · Series A | Prima Materia | 11 to 50 | Health Tech, Biotech | B2C | Lausanne, Switzerland | •••••••••••@epiterna.com | |
Accurate monitoring and treatment platform for sleep bruxism and sleep apnea. |
$3M · Seed | Zürcher Kantonal Bank, Supermoon Capital, Creadd Ventures | 1 to 10 | Health Tech, Biotech | Lausanne, Switzerland | •••••••••••@aesyra.com | ||
Molecular analysis technology developer. |
$1M · Pre Seed | Tiny VC, another.vc, Founderful | 1 to 10 | Biotech | B2B | Lausanne, Switzerland | •••••••••••@isospecanalytics.com | |
Platform for observing live cells in 3D without damaging them. |
$20M | Swisscom Ventures | 1 to 10 | Health Tech, Biotech, Pharma, Manufacturing, Business Intelligence | B2B, SaaS | Lausanne, Switzerland | •••••••••••@nanolive.ch | |
Gene and cell therapy manufacturing. |
$50M · Series A | 101 to 250 | Biotech | Lausanne, Switzerland | •••••••••••@newbiologix.com | |||
We engineered the first injectable biomaterial that stimulated the body's natural ossification process for rapid bone repair & strengthening |
$166k · Pre Seed | Venture Kick | 1 to 10 | Health Tech, Hardware, Biotech, Deep Tech, Pharma, Manufacturing, ElderTech | B2B | Lausanne, Switzerland | •••••••••••@flowbone.com | |
Protein engineering platform using cell-free synthetic biology and nanofluidics. |
$125k · Pre Seed | Y Combinator, Wingman Ventures | 1 to 10 | Health Tech, Biotech, Deep Tech, Manufacturing | B2B | Lausanne, Switzerland | •••••••••••@adaptyvbio.com | |
Rheon focuses on the development of first-in-class glaucoma drainage devices. |
$6M | 1 to 10 | Health Tech, Hardware, Biotech, Manufacturing | B2B | Lausanne, Switzerland | •••••••••••@rheonmedical.com | ||
Device that automatically inspects and sorts miniature biological entities. |
$166k · Pre Seed | Venture Kick | 1 to 10 | Health Tech, Biotech, Machine Learning, Manufacturing | B2B | Lausanne, Switzerland | •••••••••••@bionomous.ch | |
Self-testing kit provider for quick, at-home medical results. |
$1M · Seed | Next Ventures | 1 to 10 | Health Tech, Biotech, Deep Tech, Pharma, Manufacturing | B2B, B2C | Lausanne, Switzerland | •••••••••••@testmatehealth.com | |
Device improving comfort during gynecological procedures. |
$5M | 1 to 10 | Health Tech, Hardware, Biotech, Manufacturing | B2B | Lausanne, Switzerland | •••••••••••@aspivix.com | ||
Biotech firm focused on creating personalized molecular therapies for cancer patients. |
$1M · Seed | 11 to 50 | Health Tech, Biotech | B2B | Lausanne, Switzerland | •••••••••••@ac-bioscience.com | ||
Medical device designed to restore erectile function in patients unresponsive to oral medications. |
$833k · Pre Seed | 1 to 10 | Health Tech, Biotech, Deep Tech, Manufacturing | B2B | Lausanne, Switzerland | •••••••••••@comphya.com | ||
Renewable system for onsite production of solar fuel and power, offering a cleaner, greener, and cost-effective solution. |
$2M · Seed | 1 to 10 | Climate Tech & Green Tech, Biotech, Energy & Nuclear, Manufacturing | B2B | Lausanne, Switzerland | •••••••••••@sohhytec.com | ||
High-selective nerve stimulators developer for the treatment of neuropathic pain. |
N/A | 1 to 10 | Health Tech, Biotech | Lausanne, Switzerland | •••••••••••@sensars.com | |||
Tumor immunotherapy drug developer. |
$7M · Seed | Fuho Capital, XtalPi, Tiantu Capital | 1 to 10 | Biotech, Pharma | B2C | Lausanne, Switzerland | •••••••••••@lemanbio.com | |
Anti-cancer drug evaluator. |
$167k · Pre Seed | Venture Kick | 1 to 10 | Biotech, Pharma | B2B, SaaS | Lausanne, Switzerland | •••••••••••@calicobiosystems.com | |
Developer of treatments for neurodegenerative diseases. |
$100M · Series C | Novo A/S, EQT Life Sciences, Sofinnova Partners | 1 to 10 | Health Tech, Biotech | Lausanne, Switzerland | •••••••••••@asceneuron.com |
Sign up to access our full database
Enter your email and get access to 18,000+ technology companies you can partner with.